Neumora Therapeutics Prices Initial Public Offering Of 14.71M Common Shares At $17/Share
Portfolio Pulse from Benzinga Newsdesk
Neumora Therapeutics has priced its initial public offering (IPO) of 14.71 million common shares at $17 per share.
September 15, 2023 | 6:23 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Neumora Therapeutics' IPO pricing could impact its stock price in the short term.
The pricing of an IPO can have a significant impact on a company's stock price. In this case, Neumora Therapeutics has priced its IPO at $17 per share, which could attract investors and potentially drive up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100